Skip to main content
NATR
NASDAQ Life Sciences

NATURES SUNSHINE PRODUCTS INC Files Full Details of Proposed 2026 Stock Incentive Plan for Shareholder Vote

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
8
Price
$27.07
Mkt Cap
$473.931M
52W Low
$11.15
52W High
$28.14
Market data snapshot near publication time

summarizeSummary

NATURES SUNSHINE PRODUCTS INC filed a supplement to its definitive proxy statement, providing the full text of the proposed 2026 Stock Incentive Plan for shareholder approval, which could result in substantial dilution.


check_boxKey Events

  • Shareholder Vote on 2026 Stock Incentive Plan

    The filing provides the full text of the proposed 2026 Stock Incentive Plan, which shareholders will vote on at the May 6, 2026 Annual Meeting.

  • Significant Potential Dilution

    The plan seeks approval for 1,500,000 new shares, plus up to 1,467,079 shares from prior expired plans, totaling 2,967,079 shares. If all authorized shares were issued, dilution would be approximately 17%.

  • Correction of Prior Omission

    This DEFA14A corrects an oversight in the original March 27, 2026 proxy statement by including the full 2026 Plan document as an appendix.

  • Clarifications on Equity Awards

    The supplement clarifies terms regarding change-in-control vesting, executive vesting schedules, and explains higher equity grants in 2025 due to CEO transition and new executive hires.


auto_awesomeAnalysis

This DEFA14A filing is a crucial update to the definitive proxy statement filed on March 27, 2026, as it provides the complete text of the proposed 2026 Stock Incentive Plan, which was inadvertently omitted. Shareholders are scheduled to vote on this plan at the upcoming Annual Meeting on May 6, 2026. The plan, if approved, authorizes the issuance of 1,500,000 new shares, in addition to potentially re-adding up to 1,467,079 shares from expired prior plans. This combined pool of nearly 3 million shares represents a significant potential dilution of approximately 17% of the company's current outstanding shares. While stock incentive plans are standard for employee retention and motivation, the magnitude of potential dilution makes this a material consideration for investors. The filing also includes important clarifications regarding equity award treatment in change-in-control scenarios and vesting schedules, providing a more complete picture for shareholders to make an informed voting decision.

At the time of this filing, NATR was trading at $27.07 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $473.9M. The 52-week trading range was $11.15 to $28.14. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed NATR - Latest Insights

NATR
Apr 20, 2026, 5:28 PM EDT
Filing Type: DEFA14A
Importance Score:
8
NATR
Mar 27, 2026, 5:15 PM EDT
Filing Type: DEF 14A
Importance Score:
8
NATR
Mar 17, 2026, 5:11 PM EDT
Filing Type: 4
Importance Score:
7
NATR
Mar 17, 2026, 5:10 PM EDT
Filing Type: 4
Importance Score:
7
NATR
Mar 10, 2026, 5:10 PM EDT
Filing Type: 10-K
Importance Score:
9
NATR
Mar 10, 2026, 4:23 PM EDT
Source: Reuters
Importance Score:
8